COVID-19 Disease & Vaccine Survey in Africa
NCT05950243 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2025-01-27
Summary
The COVID-19 pandemic is a public health concern; for which the WHO recommends protective measures and vaccination. There is inadequate data on the impact of COVID-19 vaccination and control measures in Africa. This survey is collecting data about people's knowledge, attitude and compliance regarding COVID-19 disease and vaccines.
Conditions
- COVID-19
- Vaccine Hesitancy
Interventions
- BEHAVIORAL
-
Questionnaire
Questionnaire survey for data collection
Sponsors & Collaborators
-
Salem Anaesthesia Pain Clinic
lead OTHER
Principal Investigators
-
Olu Bamgbade, MD,FRCPC · Salem Anaesthesia Pain Clinic
Eligibility
- Min Age
- 9 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-01-02
- Primary Completion
- 2023-12-31
- Completion
- 2023-12-31
Countries
- Canada
Study Locations
More Related Trials
-
Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South Africa
NCT05539989 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Safety and Immunogenicity of MVA85A, in Healthy Volunteers in Cape Town
NCT00460590 ·Status: COMPLETED ·Phase: PHASE1
-
Study on COVID-19 Vaccine Effectiveness Among Health Workers in Azerbaijan
NCT05069454 ·Status: UNKNOWN ·Phase: NA
-
Measles Vaccine: Is There a Protective Role in COVID 19 Pandemic?
NCT04445610 ·Status: UNKNOWN
-
Intervention to Promote Childhood Vaccinations and Influence Vaccination Attitudes
NCT05425823 ·Status: COMPLETED ·Phase: NA
-
The Next Generation Vaccine Card: Innovative Technology to Improve Vaccine Equity in Rural and Urban Settings in East Africa
NCT06470919 ·Status: COMPLETED ·Phase: NA
-
A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers
NCT00423839 ·Status: COMPLETED ·Phase: PHASE1
-
mHealth-Assisted Conditional Cash Transfers to Improve Timeliness of Vaccinations (D0271)
NCT03252288 ·Status: COMPLETED ·Phase: NA
-
Dose-Defining Safety and Immunogenicity Study of MTBVAC in South African Neonates
NCT03536117 ·Status: COMPLETED ·Phase: PHASE2
-
Oxford/AstraZeneca COVID-19 Vaccine Effectiveness in England
NCT05047822 ·Status: COMPLETED
-
Increasing Vaccine Uptake Among Adolescents in the Rural South
NCT04999267 ·Status: COMPLETED ·Phase: NA
-
MTBVAC Study in Adults With and Without Latent Tuberculosis Infection in South Africa
NCT02933281 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda
NCT04177485 ·Status: COMPLETED ·Phase: NA
-
A Survey of Acceptance and Factors Associated With Hesitancy Vaccination in Northeast Brazil
NCT06675721 ·Status: NOT_YET_RECRUITING
-
A Tool Kit to Improve Vaccine Confidence in the Philippines
NCT06218368 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
BCG to Reduce Absenteeism Among Health Care Workers During the COVID-19 Pandemic
NCT04641858 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase I Study of a New Tuberculosis (TB) Vaccine, MVA85A, in Healthy Volunteers With HIV
NCT00731471 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Diagnostic Performance Evaluation of a Measles Rapid Test in Senegal
NCT05860920 ·Status: NOT_YET_RECRUITING
-
Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and Adults
NCT06062238 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
The Role of BCG Vaccine in the Clinical Evolution of COVID-19 and in the Efficacy of Anti-SARS-CoV-2 Vaccines
NCT05507671 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Pertussis Immunization Programs in Low Income Countries - Ivory Coast
NCT03388034 ·Status: COMPLETED
-
BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots
NCT04475302 ·Status: COMPLETED ·Phase: PHASE3
-
Pertussis Immunization Programs in Low Income Countries
NCT02983487 ·Status: COMPLETED
-
Role of mHealth-based Interventions Including Social Media to Improve Childhood Immunization Coverage During COVID 19 Pandemic in Pakistan: Qualitative Study
NCT05042011 ·Status: UNKNOWN
-
BCG Revaccination With the Third Dose of Diphtheria-tetanus-pertussis Vaccine and Infant Mortality in Africa
NCT07005726 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4